Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/130844 |
Resumo: | OBJECTIVE: Esophageal squamous cell carcinoma is one of the most common esophageal diseases in the developing world, but the relationship between esophageal squamous cell carcinoma and Helicobacter pylori infection remains a neglected topic. The primary objective of this study was to determine the association between Helicobacter pylori infection and esophageal squamous cell carcinoma. A second purpose was to determine the incidence and factors associated with Helicobacter pylori infection following esophagectomy. METHOD: The microorganism was identified by testing the gastric biopsy materials from 95 esophageal squamous cell carcinoma patients (66 females; 39 were esophagectomized) for urease activity in a medium containing urea and a power of hydrogen detection reagent and comparing the results with those from a healthy population. Differences in patient characteristics were assessed with chi-square tests and t-tests for categorical and continuous factors, respectively. RESULTS: The patients with esophageal squamous cell carcinoma had a significantly lower prevalence of Helicobacter pylori compared with the healthy population (p;0.005). Patients with esophageal squamous cell carcinoma showed a significant association between leukocytosis and hypoglobulinemia and the presence of Helicobacter pylori infection (p=0.023 and p=0.045, respectively). CONCLUSION: These results suggest that Helicobacter pylori is not an etiological factor in patients with esophageal squamous cell carcinoma. We found a statistically significant negative correlation between esophageal squamous cell cancer and Helicobacter pylori infection. These findings may guide new strategies for esophageal squamous cell carcinoma therapy. |
id |
USP-19_24b4b350891cc2a332b9e07e28ccdddf |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/130844 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinomaHelicobacter pyloriEsophageal Squamous Cell CarcinomaTurkeyOBJECTIVE: Esophageal squamous cell carcinoma is one of the most common esophageal diseases in the developing world, but the relationship between esophageal squamous cell carcinoma and Helicobacter pylori infection remains a neglected topic. The primary objective of this study was to determine the association between Helicobacter pylori infection and esophageal squamous cell carcinoma. A second purpose was to determine the incidence and factors associated with Helicobacter pylori infection following esophagectomy. METHOD: The microorganism was identified by testing the gastric biopsy materials from 95 esophageal squamous cell carcinoma patients (66 females; 39 were esophagectomized) for urease activity in a medium containing urea and a power of hydrogen detection reagent and comparing the results with those from a healthy population. Differences in patient characteristics were assessed with chi-square tests and t-tests for categorical and continuous factors, respectively. RESULTS: The patients with esophageal squamous cell carcinoma had a significantly lower prevalence of Helicobacter pylori compared with the healthy population (p;0.005). Patients with esophageal squamous cell carcinoma showed a significant association between leukocytosis and hypoglobulinemia and the presence of Helicobacter pylori infection (p=0.023 and p=0.045, respectively). CONCLUSION: These results suggest that Helicobacter pylori is not an etiological factor in patients with esophageal squamous cell carcinoma. We found a statistically significant negative correlation between esophageal squamous cell cancer and Helicobacter pylori infection. These findings may guide new strategies for esophageal squamous cell carcinoma therapy.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2017-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/13084410.6061/clinics/2017(03)04Clinics; Vol. 72 No. 3 (2017); 150-153Clinics; v. 72 n. 3 (2017); 150-153Clinics; Vol. 72 Núm. 3 (2017); 150-1531980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/130844/127283Copyright (c) 2017 Clinicsinfo:eu-repo/semantics/openAccessPoyrazoglu, Omer BilgehanDulger, Ahmet CumhurGultepe, Bilge Sumbul2017-04-10T16:00:51Zoai:revistas.usp.br:article/130844Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2017-04-10T16:00:51Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
title |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
spellingShingle |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma Poyrazoglu, Omer Bilgehan Helicobacter pylori Esophageal Squamous Cell Carcinoma Turkey |
title_short |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
title_full |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
title_fullStr |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
title_full_unstemmed |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
title_sort |
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma |
author |
Poyrazoglu, Omer Bilgehan |
author_facet |
Poyrazoglu, Omer Bilgehan Dulger, Ahmet Cumhur Gultepe, Bilge Sumbul |
author_role |
author |
author2 |
Dulger, Ahmet Cumhur Gultepe, Bilge Sumbul |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Poyrazoglu, Omer Bilgehan Dulger, Ahmet Cumhur Gultepe, Bilge Sumbul |
dc.subject.por.fl_str_mv |
Helicobacter pylori Esophageal Squamous Cell Carcinoma Turkey |
topic |
Helicobacter pylori Esophageal Squamous Cell Carcinoma Turkey |
description |
OBJECTIVE: Esophageal squamous cell carcinoma is one of the most common esophageal diseases in the developing world, but the relationship between esophageal squamous cell carcinoma and Helicobacter pylori infection remains a neglected topic. The primary objective of this study was to determine the association between Helicobacter pylori infection and esophageal squamous cell carcinoma. A second purpose was to determine the incidence and factors associated with Helicobacter pylori infection following esophagectomy. METHOD: The microorganism was identified by testing the gastric biopsy materials from 95 esophageal squamous cell carcinoma patients (66 females; 39 were esophagectomized) for urease activity in a medium containing urea and a power of hydrogen detection reagent and comparing the results with those from a healthy population. Differences in patient characteristics were assessed with chi-square tests and t-tests for categorical and continuous factors, respectively. RESULTS: The patients with esophageal squamous cell carcinoma had a significantly lower prevalence of Helicobacter pylori compared with the healthy population (p;0.005). Patients with esophageal squamous cell carcinoma showed a significant association between leukocytosis and hypoglobulinemia and the presence of Helicobacter pylori infection (p=0.023 and p=0.045, respectively). CONCLUSION: These results suggest that Helicobacter pylori is not an etiological factor in patients with esophageal squamous cell carcinoma. We found a statistically significant negative correlation between esophageal squamous cell cancer and Helicobacter pylori infection. These findings may guide new strategies for esophageal squamous cell carcinoma therapy. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-03-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/130844 10.6061/clinics/2017(03)04 |
url |
https://www.revistas.usp.br/clinics/article/view/130844 |
identifier_str_mv |
10.6061/clinics/2017(03)04 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/130844/127283 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2017 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2017 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 72 No. 3 (2017); 150-153 Clinics; v. 72 n. 3 (2017); 150-153 Clinics; Vol. 72 Núm. 3 (2017); 150-153 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222763134222336 |